scispace - formally typeset
Journal ArticleDOI

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)

TLDR
Individuals coinfected with HIV-1 and HBV, especially those with low CD4+ nadir counts, are at increased risk for liver-related mortality, underscoring the importance of prevention, identification, and comprehensive management of hepatitis B in people infected withAIDS.
Citations
More filters
Journal ArticleDOI

HBV Infection in HIV-Driven Immune Suppression

TL;DR: The main aspects of HBV infection in HIV-positive patients are summarized, emphasizing the importance of carefully considering the coinfected patient in the context of therapeutic strategies of antiretroviral therapy.
Journal ArticleDOI

Influence of HIV-associated degree of immune suppression on molecular heterogeneity of hepatitis B virus among HIV co-infected patients.

TL;DR: Cutting genetic diversity and increased viral load in the HBV/D2 isolates might facilitate the maintenance of their wild type characteristics in the low CD4 count, leading to its increased prevalence in this group.
Journal ArticleDOI

The burden of hepatitis B virus (HBV) infection, genotypes and drug resistance mutations in human immunodeficiency virus-positive patients in Northwest Ethiopia.

TL;DR: The prevalence of HBV, HBV genotypes, and drug resistance mutations in dual infected cases in a cohort of HIV patients in Northwest Ethiopia found 5.5% HBV/HIV co-infected cases, underscoring the importance of integrating HBV screening to the HIV treatment guidelines for better management and prevention ofHBV-related liver disease.
Journal ArticleDOI

Factors influencing liver disease progression in chronic hepatitis B

TL;DR: An enhanced understanding of factors associated with HBV disease progression may lead to improvements in the selection of candidates for intervention and overall disease management.
Journal ArticleDOI

Antiretroviral therapy : pharmacokinetic considerations in patients with renal or hepatic impairment.

TL;DR: The current knowledge of the use of antiretrovirals in patients with hepatic or renal impairment is summarized, and dosing recommendations for this subpopulation of HIV-infected patients are made.
References
More filters
Journal Article

Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.

TL;DR: What do you do to start reading statistical methods in cancer research vol ii the design and analysis of cohort studies?
Journal ArticleDOI

The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994

TL;DR: The strongest factors independently associated with HCV infection were illegal drug use and high-risk sexual behavior, and poverty, having had 12 or fewer years of education, and having been divorced or separated were independently associated.
Journal ArticleDOI

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients

TL;DR: In coinfected patients, a low CD4 count, alcohol consumption rate, and age at HCV infection are associated with a higher liver fibrosis progression rate, while HIV seropositivity accelerates HCV‐related liver Fibrosis progression.
Journal ArticleDOI

The multicenter aids cohort study: rationale, organization, and selected characteristics of the participants

TL;DR: The Multicenter AIDS Cohort Study was designed to elucidate the natural history of the infection causing acquired immunodeficiency syndrome (AIDS), identify risk factors for occurrence and clinical expression of the virus, and establish a repository of biologic specimens for future study.
Journal ArticleDOI

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.

TL;DR: The data indicate that use of ritonavir may increase risk of severe hepatotoxicity, and does not support withholding protease inhibitor therapy from persons coinfected with hepatitis B or C virus.
Related Papers (5)